Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
| Registrars: |
| CEO: | Riad Mishlawi |
| Non-Executive Director: | Ali Al-Husry |
| Executive Chairman: | Said Darwazah |
| Independent Non-Executive Director: | Cynthia Schwalm, Deneen Vojta, Douglas Hurt, John J. Castellani, Laura Balan Balan, Mary (Nina) Henderson, Victoria Hull |
| Executive Vice Chairman: | Mazen Darwazah |
| Address: | 1 New Burlington Place, London,United Kingdom |
| Phone: | +44 (0)20 7399 2760 |
| Fax: | +44 (0)20 7399 2761 |
| Website: | http://www.hikma.com |
| Email: |
| ISIN: | GB00B0LCW083 |
| Sector: | Pharma and Biotech, Pharma and Biotech |
| Main Indices: | FTSE 100, FTSE 350, FTSE All-Share |